MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 235 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $612,605 | +32.4% | 70,658 | 0.0% | 0.00% | – |
| Q4 2023 | $462,810 | -34.5% | 70,658 | 0.0% | 0.00% | – |
| Q3 2023 | $706,580 | -17.5% | 70,658 | +2.6% | 0.00% | – |
| Q2 2023 | $856,166 | +105.8% | 68,879 | +132.0% | 0.00% | – |
| Q1 2023 | $415,999 | -8.0% | 29,693 | -6.1% | 0.00% | – |
| Q4 2022 | $452,396 | -21.2% | 31,614 | +40.7% | 0.00% | – |
| Q3 2022 | $574,000 | +6.7% | 22,465 | +18.6% | 0.00% | – |
| Q2 2022 | $538,000 | +127.0% | 18,949 | +182.4% | 0.00% | – |
| Q1 2022 | $237,000 | -59.1% | 6,710 | -51.5% | 0.00% | – |
| Q4 2021 | $580,000 | +56.8% | 13,833 | +83.4% | 0.00% | – |
| Q3 2021 | $370,000 | +44.5% | 7,542 | +22.8% | 0.00% | – |
| Q2 2021 | $256,000 | -43.4% | 6,140 | -61.9% | 0.00% | – |
| Q4 2020 | $452,000 | – | 16,116 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $269,495,240 | 12.63% |
| 12 West Capital Management LP | 3,361,836 | $41,787,621 | 3.59% |
| Alpine Peaks Capital, LP | 329,424 | $4,094,740 | 2.87% |
| Roubaix Capital, LLC | 235,480 | $2,927,016 | 2.15% |
| Prosight Management, LP | 628,600 | $7,813,498 | 1.17% |
| Cannon Global Investment Management, LLC | 15,800 | $196,394 | 1.02% |
| Curi Wealth Management, LLC | 566,417 | $7,040,564 | 0.95% |
| Mesirow Institutional Investment Management, Inc. | 693,376 | $8,618,664 | 0.89% |
| BRAIDWELL LP | 1,804,700 | $22,432,421 | 0.73% |
| Connacht Asset Management LP | 39,031 | $485,155 | 0.66% |